MedPath

Study of effect of treatment versus no treatment on seizures, psychological, behavioral and EEG parameters in children with BECTS type of epilepsy

Suspended
Conditions
Children suffering from Benign Epilepsy with centro-temporal spikes ( BECTS)
Registration Number
CTRI/2018/02/012248
Lead Sponsor
Bharati Vidyapeeth Medical College Pune
Brief Summary

After screening for eligibility, patients will be randomized to treatment or No treatment group. At baseline, both groups will undergo EEG, neuro-psychological and language testing. These tests will be repeated at the end of 1 and 2 years on follow up. In the treatment group, Valproate will be started, follow up will be done 3 monthly, including for monitoring for any side effects . In no treatment group, follow up will be done 3 monthly. The difference in these parameters in both the groups will be studied at the end of 2 years

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Onset of seizures after the age of 3 years 2.
  • History of at least one typical seizure 3.
  • Normal neurological and development history 4.Clinical and EEG criteria suggestive of BECTS according to ILAE criteria 5.
  • No other seizure type.
Exclusion Criteria
  • Prior neurological deficits 2.
  • Pre-existing psychiatric conditions 3.
  • Symptomatic etiology 4.
  • 3 or more seizures in last 3 months 5.
  • Already on anti-epileptics for more than a week.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the changes in cognition ( IQ), language, behavior and academic achievement of children with newly diagnosed BECTS, between the no treatment group versus the Treatment group; from baseline to follow up over 2 years.3 monthly till 2 years
Secondary Outcome Measures
NameTimeMethod
i) To study the clinical and the EEG profile in these children at baseline and further till 2 yearsii) To compare the seizure recurrence rates between the two groups

Trial Locations

Locations (2)

Bharati Vidyapeeth University Medical College Pune

🇮🇳

Pune, MAHARASHTRA, India

Jaslok Hospital, Mumbai

🇮🇳

Mumbai, MAHARASHTRA, India

Bharati Vidyapeeth University Medical College Pune
🇮🇳Pune, MAHARASHTRA, India
Dr Kavita Srivastava
Principal investigator
9850825791
kavisri1970@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.